Bio & Pharma
S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma
Getting approval from the Fair Trade Commission, Geo-young expects synergy between customer expansion and export promotion
By Jun 14, 2023 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


Mirae Asset to be named Korea Post’s core real estate fund operator


KT&G eyes overseas M&A after rejecting activist fund's offer


Meritz backs half of ex-manager’s $210 mn hedge fund


StockX in merger talks with Naver’s online reseller Kream



South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.
Geo-young on Tuesday said the Fair Trade Commission approved the transaction. Founded in 2002, the company has 80% of domestic pharmacies as customers and tops its sector in sales.
The stake purchase is in line with the aggressive overseas advance of the nation’s healthcare industry by promoting exports of domestic medicine and medical devices.
“Geo-young and Baekje Pharmaceutical will create business synergy by using each other’s strengths,” a Geo-young source said. “This collaboration will be an important inflection point for raising the competitiveness of domestic pharmaceutical distribution overall and advancing its business.”
Write to Ji-Hyun Lee at bluesky@hankyung.com
More to Read
-
-
AutomobilesBMW surpasses Mercedes in Korean sales for 1st time in 10 years
May 02, 2025 (Gmt+09:00)
-
Business & PoliticsTrump Jr. meets Korean business chiefs in back-to-back sessions
Apr 30, 2025 (Gmt+09:00)
-
Korean chipmakersSamsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
Apr 30, 2025 (Gmt+09:00)
-
EnergyLS Cable breaks ground on $681 mn underwater cable plant in Chesapeake
Apr 29, 2025 (Gmt+09:00)
Comment 0
LOG IN